Jeng YM - Search Results

1

CTP synthase forms the cytoophidium in human hepatocellular carcinoma.

Chang CC, Jeng YM, Peng M, Keppeke GD, Sung LY, Liu JL. Chang CC, et al. Among authors: jeng ym. Exp Cell Res. 2017 Dec 15;361(2):292-299. doi: 10.1016/j.yexcr.2017.10.030. Epub 2017 Oct 31. Exp Cell Res. 2017. PMID: 29097181

2

Overexpression and amplification of Aurora-A in hepatocellular carcinoma.

Jeng YM, Peng SY, Lin CY, Hsu HC. Jeng YM, et al. Clin Cancer Res. 2004 Mar 15;10(6):2065-71. doi: 10.1158/1078-0432.ccr-1057-03. Clin Cancer Res. 2004. PMID: 15041727

3

Decreased expressions of hepsin in human hepatocellular carcinomas.

Chen CH, Su KY, Tao MH, Lin SW, Su YH, Tsai YC, Cheng KC, Jeng YM, Sheu JC. Chen CH, et al. Among authors: jeng ym. Liver Int. 2006 Sep;26(7):774-80. doi: 10.1111/j.1478-3231.2006.01307.x. Liver Int. 2006. PMID: 16911458

4

Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.

Chen CH, Lee HS, Huang GT, Yang PM, Yu WY, Cheng KC, Lee PH, Jeng YM, Chen DS, Sheu JC. Chen CH, et al. Among authors: jeng ym. Hepatogastroenterology. 2007 Jul-Aug;54(77):1529-33. Hepatogastroenterology. 2007. PMID: 17708291

5

ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.

Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, Peng SY, Lai PL, Hsu HC. Lin SY, et al. Among authors: jeng ym. Clin Cancer Res. 2008 Aug 1;14(15):4814-20. doi: 10.1158/1078-0432.CCR-07-5262. Clin Cancer Res. 2008. PMID: 18676753

6

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM. Wang YC, et al. Among authors: jeng ym. Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4. Carcinogenesis. 2010. PMID: 20525879

7

S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.

Yuan RH, Chang KT, Chen YL, Hsu HC, Lee PH, Lai PL, Jeng YM. Yuan RH, et al. Among authors: jeng ym. PLoS One. 2013 Jun 13;8(6):e65501. doi: 10.1371/journal.pone.0065501. Print 2013. PLoS One. 2013. PMID: 23785431 Free PMC article.

8

Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.

Lee HJ, Jeng YM, Chen YL, Chung L, Yuan RH. Lee HJ, et al. Among authors: jeng ym. Carcinogenesis. 2014 Apr;35(4):769-75. doi: 10.1093/carcin/bgt372. Epub 2013 Nov 14. Carcinogenesis. 2014. PMID: 24233839

9

RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.

Chua HH, Tsuei DJ, Lee PH, Jeng YM, Lu J, Wu JF, Su DS, Chen YH, Chien CS, Kao PC, Lee CN, Hu RH, Ni YH, Chang MH. Chua HH, et al. Among authors: jeng ym. Hepatology. 2015 Nov;62(5):1480-96. doi: 10.1002/hep.27996. Epub 2015 Aug 25. Hepatology. 2015. PMID: 26185016

10

Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells.

Kuo TC, Chen CK, Hua KT, Yu P, Lee WJ, Chen MW, Jeng YM, Chien MH, Kuo KT, Hsiao M, Kuo ML. Kuo TC, et al. Among authors: jeng ym. Cancer Lett. 2016 Dec 28;383(2):282-294. doi: 10.1016/j.canlet.2016.10.012. Epub 2016 Oct 8. Cancer Lett. 2016. PMID: 27725225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters